Several factors influence individual response to BPC-157 therapy for rib injuries: Age affects baseline healing capacity
doi:10.1007/s00394-010-0119-6
A vial priced far below the market is either underdosed, impure, or stored badly somewhere along the chain, and any of those wipes out the savings the moment your results stall
Tirzepatide vs semaglutide 2.4 mg in non-diabetic obesity SURMOUNT-5 direct head-to-head, -20.2% vs -13.7% at 72 weeks: Aronne NEJM 2025
PubMed laboratory research record [PMID: 2622900] PubMed record related to this compound for laboratory literature review
Clinical experience suggests good tolerability, with: Mild injection site reactions Occasional digestive changes (particularly with oral administration) Rarely reported headache Important Safety Considerations Both peptides should be prescribed and monitored by qualified medical providers Quality of peptide sourcing matters compounding pharmacies should be licensed and regulated Lab monitoring (particularly IGF-1 for sermorelin) is essential for ongoing safety Contraindications (active malignancies, certain medical conditions) must be evaluated Medical Disclaimer Sermorelin was previously FDA-approved for diagnostic use (Geref Diagnostic) and is currently prescribed off-label through compounding pharmacies